FDA inspection
Shanghai Hengrui Pharmaceutical Co., Ltd.: FDA inspection ending Oct 25, 2024
FDA inspection 1252840 · Voluntary Action Indicated (VAI) · Shanghai
Key facts
| Inspection ID | 1252840 |
|---|---|
| Firm | Shanghai Hengrui Pharmaceutical Co., Ltd. |
| FEI number | 3003910445 |
| Address | No 279 Wenjing Road, Minxing |
| City | Shanghai |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Oct 25, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data